Survival and echocardiographic evaluation of dogs with idiopathic dilated cardiomyopathy treated with carvedilol

• Autor(a) principal: Soares,E.C.
• Data de Publicação: 2010
• Outros Autores: Pereira,G.G., Petrus,L.C., Leomil Neto,M., Yamaki,F.L., Larsson,M.H.M.A.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Arquivo brasileiro de medicina veterinária e zootecnia (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352010000300009
• topic: dog; cardiomyopathy; carvedilol; heart failure; echocardiography

Sixty dogs with idiopathic dilated cardiomyopathy were randomly treated with traditional therapy - digitalis, diuretics, angiotensin-converting inhibitors - (group A) or treated with these drugs plus carvedilol (group B). Echocardiographic variables were measured before and after 3, 13, 26, and 52 weeks of treatment or until death. Comparisons between groups and time were performed. No significant differences between groups were found in the most of the echocardiographic variables. The left ventricular end-systolic diameter indexed to body surface area (LVESDi) increased significantly in the group A dogs compared to the group B animals. The survival of groups A and B dogs were not different (P-value=0.1137). In conclusion, the stability of the LVESDi observed in the group treated with carvedilol may represent the beneficial effect over the ventricular remodeling.